Century Therapeutics
IPSC
72 hedge funds and large institutions have $36.8M invested in Century Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 10 reducing their positions, and 10 closing their positions.
400% more call options, than puts
Call options by funds: $10K | Put options by funds: $2K
200% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 10
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
7% more funds holding
Funds holding: 67 → 72 (+5)
3.99% less ownership
Funds ownership: 46.8% → 42.81% (-4%)
46% less capital invested
Capital invested by funds: $67.8M → $36.8M (-$31M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
+$2.69M |
| 2 |
Millennium Management
New York
|
+$2M |
| 3 |
Renaissance Technologies
New York
|
+$973K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$683K |
| 5 |
SCM
Superstring Capital Management
New York
|
+$630K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.72M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.26M |
| 3 |
VA
VR Adviser
New York
|
-$1.95M |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$1.14M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$284K |
IPSC Hedge Fund Activity: Q4 2024 in Review
72 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q4 2024, worth a combined $36.8M — down 46% from $67.8M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new IPSC positions and 10 closed out — a net gain of 5 holders — while 30 added to existing stakes and 10 trimmed.
The largest buyer was Casdin Capital, adding an estimated $2.69M. The largest seller was Morgan Stanley, cutting an estimated $2.72M.
- 72 institutional investors held Century Therapeutics (IPSC) as of Q4 2024, up from 67 in Q3 2024.
- Funds reported $36.8M of Century Therapeutics stock for Q4 2024, down 46% quarter-over-quarter.
- 15 funds opened new Century Therapeutics positions in Q4 2024 and 10 closed out, a net change of +5 holders.
- The largest Century Therapeutics buyer in Q4 2024 was Casdin Capital, an estimated $2.69M added.
- The largest Century Therapeutics seller in Q4 2024 was Morgan Stanley, an estimated $2.72M sold.
Based on aggregated 13F filings for Q4 2024.